Mitsubishi International Corporation (MIC) appeared to be the VC, which was created in 1870. The fund was located in North America if to be more exact in United States. Mitsubishi International Corporation (MIC) appeared to be a CVC structure as part of the corporation. The leading representative office of defined VC is situated in the Andover.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Mitsubishi International Corporation (MIC), startups are often financed by Alta Partners, Walden International, TIAA. The meaningful sponsors for the fund in investment in the same round are Domain Associates, Western Technology Investment, Walden International. In the next rounds fund is usually obtained by Sigma Partners, Mohr Davidow Ventures, Mayfield Fund.
This Mitsubishi International Corporation (MIC) works on 46 percentage points more the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2001. The fund is constantly included in less than 2 deals per year. When the investment is from Mitsubishi International Corporation (MIC) the average startup value is 50-100 millions dollars. The top amount of exits for fund were in 2004. Considering the real fund results, this VC is 12 percentage points less often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Among the most popular portfolio startups of the fund, we may highlight NetLogic Microsystems, Annuncio Software, Accelight Networks. Among the most popular fund investment industries, there are Pharmaceutical, Therapeutics. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
Related Funds
Funds with similar focus
Fund Name | Location |
Armen Capital Management | - |
Creabilis | Emilia-Romagna, Italy, Samone |
ERBAN | Kayseri, Kayseri, Turkey |
Fresh Your Life | Beijing, Beijing, China |
Front Street Capital | Canada, Ontario, Toronto |
GAIN - Guadalajara Angel Investor Network | Durango, Jalisco, Mexico |
JC2 Ventures | - |
Jinyongxin Investment Management | China, Hangzhou, Zhejiang |
KLab | Chiyoda, Japan |
Kukula Capital | Lusaka, Lusaka, Zambia |
Mutianfeng Medical Equipment Technology | China, Guangdong, Shenzhen |
NewRoad Capital Partners | Arkansas, Rogers, United States |
Principal Financial Group | Des Moines, Iowa, United States |
Qidi Yinxing | Beijing, China, Haidian |
Sidaoke Touzi | China, Guangdong, Shenzhen |
Startup42 | France, Ile-de-France, Paris |
Thyra Global Management | New York, New York, United States |
Yasuda Ventures | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Cara Therapeutics | $12M | 25 Jul 2008 | Connecticut, United States | ||
$30M | 31 Jan 2008 | San Diego, California, United States | |||
Panacea Pharmaceuticals | $7M | 08 Jul 2005 | Maryland, United States | ||
BioMimetic Therapeutics | $11M | 18 May 2005 | Franklin, Tennessee, United States | ||
BioMimetic Therapeutics | $25M | 05 Nov 2004 | Franklin, Tennessee, United States | ||
OmniSonics Medical Technologies | $43M | 10 Oct 2003 | - | ||
BoostWorks | $9M | 04 Mar 2003 | San Francisco, California, United States | ||
Peninsula Pharmaceuticals | $22M | 28 Oct 2002 | California, United States | ||
TradeBeam | $6M | 18 Apr 2002 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Cara Therapeutics | $12M | 25 Jul 2008 | Connecticut, United States | ||
$30M | 31 Jan 2008 | San Diego, California, United States | |||
Panacea Pharmaceuticals | $7M | 08 Jul 2005 | Maryland, United States | ||
BioMimetic Therapeutics | $11M | 18 May 2005 | Franklin, Tennessee, United States | ||
BioMimetic Therapeutics | $25M | 05 Nov 2004 | Franklin, Tennessee, United States | ||
OmniSonics Medical Technologies | $43M | 10 Oct 2003 | - | ||
BoostWorks | $9M | 04 Mar 2003 | San Francisco, California, United States | ||
Peninsula Pharmaceuticals | $22M | 28 Oct 2002 | California, United States | ||
TradeBeam | $6M | 18 Apr 2002 | California, United States |